Changeflow GovPing Government & Legislation National Health (Pharmaceutical Benefits Scheme...
Routine Rule Amended Final

National Health (Pharmaceutical Benefits Scheme Exempt Items) Determination 2017 (F2026C00335)

Favicon for www.legislation.gov.au AU Federal Legislative Instruments (7-day)
Published
Detected
Email

Summary

The Australian Department of Health, Disability and Ageing has published the latest version (F2026C00335) of the National Health (Pharmaceutical Benefits Scheme - Exempt Items - Section 84AH) Determination 2017 under the National Health Act 1953. This legislative instrument specifies items exempt from the Pharmaceutical Benefits Scheme, with this consolidated version effective 1 April 2026. The instrument is administered by the Department of Health, Disability and Ageing and remains in force.

Published by DoH AU on legislation.gov.au . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This instrument provides the latest consolidated version of the National Health (Pharmaceutical Benefits Scheme Exempt Items - Section 84AH) Determination 2017, originally made under the National Health Act 1953. Section 84AH deals with exempt items under the PBS framework.

Affected parties including pharmaceutical manufacturers, healthcare providers, and patients should verify current exempt item classifications. The instrument forms part of the regulatory framework governing pharmaceutical subsidy arrangements in Australia. Stakeholders should consult the Schedule section for specific item listings.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

- Interactions

National Health (Pharmaceutical Benefits Scheme‑Exempt items ‑ Section 84AH) Determination 2017

In force Administered by
- Department of Health, Disability and Ageing
This item is authorised by the following title:


View document Legislative instrument Filter active Table of contents
- 1 Name of Instrument
- 4 Authority
- 5 Definitions
- 6 Exempt items
- Schedule
- Endnotes
- Endnote 1—About the endnotes
- Endnote 2—Abbreviation key
- Endnote 3—Legislation history
- Endnote 4—Amendment history

Named provisions

Name of Instrument Authority Definitions Exempt items Schedule

Get daily alerts for AU Federal Legislative Instruments (7-day)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DoH AU.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DoH AU
Published
April 1st, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
F2026C00335
Docket
F2017L01265
Supersedes
F2017L01265

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Patients
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
PBS subsidy arrangements Exempt item classification Pharmaceutical regulation
Geographic scope
Australia AU

Taxonomy

Primary area
Healthcare
Operational domain
Regulatory Affairs
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when AU Federal Legislative Instruments (7-day) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!